| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.3 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |